| 2023-05-22 | +79.1% | news | Seeking Alpha | Microbot Medical announces $1.4M registered direct offering priced at-the-market |
| 2023-05-23 | -38.3% | news | Seeking Alpha | Microbot Medical announces $2.7M direct offering of common stock at $2.20 per share |
| 2023-12-29 | -34.3% | news | Seeking Alpha | Microbot Medical down 22%, exercises investment options for $2.73M proceeds |
| 2025-01-07 | -33.2% | legal | SEC EDGAR | MBOT 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2025-01-06 | +32.8% | news | Seeking Alpha | Microbot Medical rises as it looks to raise $7M in direct offering |
| 2025-01-06 | +32.8% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2025-01-08 | -30.4% | news | Seeking Alpha | Microbot Medical announces $8.6M registered direct offering |
| 2025-11-26 | +27.5% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-11-26 | +27.5% | news | Stock Titan | Microbot Medical (Nasdaq: MBOT) adds Emory as first LIBERTY endovascular robotics site - Stock Titan |
| 2025-11-26 | +27.5% | news | timothysykes.com | Microbot Medical’s Bold Move: Robotic System Release - timothysykes.com |
| 2026-02-24 | +24.8% | legal | SEC EDGAR | MBOT 8-K: 1.01, 5.02 (SEC Filing) |
| 2026-02-24 | +24.8% | news | Stock Titan | Tampa General turns to single-use vascular surgery robot LIBERTY - Stock Titan |
| 2026-02-24 | +24.8% | news | Benzinga | Tampa General Hospital Adopts Small-Cap Microbot Medical's Robotic System - Benzinga |
| 2026-02-24 | +24.8% | news | TipRanks | Microbot Medical gains key Florida adopter for LIBERTY system - TipRanks |
| 2023-12-28 | +24.5% | news | Seeking Alpha | Microbot to advance Liberty Robotic System into pivotal clinical trial |
| 2025-04-09 | +23.1% | news | Seeking Alpha | Microbot Medical rises as robotic surgical system succeeds in pivotal trial |
| 2025-04-09 | +23.1% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-09-09 | -21.2% | legal | Yahoo Finance | Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System - Yahoo Finance |
| 2025-09-09 | -21.2% | legal | Globes - Israel Business News | Microbot Medical share price jumps after FDA approval - Globes - Israel Business News |
| 2025-02-10 | -21.1% | news | Seeking Alpha | Microbot Medical announces $13 million registered direct offering |
| 2025-02-10 | -21.1% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2025-09-15 | -17.9% | news | MassDevice | Microbot Medical to raise over $92M from stock sale - MassDevice |
| 2024-06-04 | -17.2% | news | Seeking Alpha | Microbot Medical stock dips on $2.35M equity offering |
| 2024-06-04 | -17.2% | legal | SEC EDGAR | MBOT 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2026-03-10 | +16.6% | news | GlobeNewswire | Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time |
| 2026-03-10 | +16.6% | news | Stock Titan | Single-use surgery robot aiming to cut radiation gets investor spotlight - Stock Titan |
| 2026-03-10 | +16.6% | news | TipRanks | Microbot Medical Highlights LIBERTY Progress at Oppenheimer Conference - TipRanks |
| 2023-10-17 | +16.3% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2023-06-27 | -16.2% | news | Seeking Alpha | Microbot Medical prices $2M direct offering |
| 2025-08-20 | +15.9% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-08-21 | +15.2% | news | Yahoo Finance | Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market - Yahoo Finance |
| 2025-04-23 | +14.8% | legal | SEC EDGAR | MBOT 8-K: 3.02, 7.01 (SEC Filing) |
| 2024-01-02 | -13.9% | legal | SEC EDGAR | MBOT 8-K: 1.01, 3.02 (SEC Filing) |
| 2024-01-02 | -13.9% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-06-03 | +13.8% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2022-10-21 | -12.3% | legal | Seeking Alpha | Microbot Medical stock slides on $5M securities offering |
| 2025-02-03 | +12.0% | news | Yahoo Finance | Why Microbot Medical Inc. (MBOT) Is Skyrocketing So Far In 2025 - Yahoo Finance |
| 2025-02-04 | +11.6% | news | Seeking Alpha | Microbot Medical files to sell about 16M shares of common stock by holders |
| 2025-04-15 | +10.4% | news | Investing.com UK | Microbot Medical modifies shareholder meeting quorum By Investing.com - Investing.com UK |
| 2026-04-11 | -10.2% | news | The Globe and Mail | Microbot Medical Expands At-The-Market Equity Offering Program - The Globe and Mail |
| 2026-02-12 | +10.0% | legal | Stock Titan | The only FDA-cleared single-use vascular robot just took center stage in Miami - Stock Titan |
| 2026-02-12 | +10.0% | news | TipRanks | Microbot Medical Highlights LIBERTY Robotics at ISET Symposium - TipRanks |
| 2024-01-12 | -9.7% | news | Seeking Alpha | Microbot Medical files to sell 1.77M shares for its holders |
| 2024-01-12 | -9.7% | legal | SEC EDGAR | MBOT 8-K: 5.02 and (SEC Filing) |
| 2026-02-10 | +9.0% | analyst | Investing.com | B.Riley initiates coverage on Microbot Medical stock with Buy rating - Investing.com |
| 2026-02-10 | +9.0% | news | StocksToTrade | Microbot Medical Advances with LIBERTY Clearance Driving Market Expansion - StocksToTrade |
| 2026-04-13 | -8.4% | news | GlobeNewswire | Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting |
| 2026-04-13 | -8.4% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2026-04-13 | -8.4% | legal | Stock Titan | Only FDA-cleared single-use endovascular robot expands U.S. rollout - Stock Titan |
| 2026-04-13 | -8.4% | news | Stock Titan | LIBERTY robot rollout widens for Microbot Medical (NASDAQ: MBOT) - Stock Titan |
| 2026-04-13 | -8.4% | news | GlobeNewswire | Microbot Medical® Commences Full Market Release (FMR) of - GlobeNewswire |
| 2025-06-09 | -8.1% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-06-09 | -8.1% | earnings | Stock Titan | Microbot Medical Reveals FDA Timeline, Expands Commercial Team for Q3 2025 LIBERTY System Launch - Stock Titan |
| 2025-04-18 | -8.1% | analyst | Yahoo Finance | Is Microbot Medical Inc. (MBOT) the Best Rising Penny Stock to Buy According to Analysts? - Yahoo Finance |
| 2025-08-05 | +8.0% | legal | SEC EDGAR | MBOT 8-K: 3.02, 7.01, 8.01 (SEC Filing) |
| 2025-09-17 | -7.8% | legal | simplywall.st | Microbot Medical (MBOT) Is Up After FDA Clears LIBERTY System and $92 Million Funding Plan—What’s Next? - simplywall.st |
| 2023-06-02 | -7.7% | news | Seeking Alpha | Microbot Medical falls on $1.5M registered direct offering |
| 2025-03-23 | -7.7% | analyst | Quiver Quantitative | MBOT | Microbot Medical, Inc. Common Analyst Forecasts - Quiver Quantitative |
| 2026-04-20 | -7.3% | news | Xã Thanh Hà | How to Manage Microbot Medical (MBOT) Stock Risk (Modest Decline) 2026-04-20 - Hot Community Stocks - Xã Thanh Hà |
| 2025-04-17 | -7.1% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2024-07-03 | +7.1% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2023-10-19 | -6.8% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2025-02-07 | +6.7% | legal | SEC EDGAR | MBOT 8-K: 1.01, 5.02 (SEC Filing) |
| 2025-02-11 | -6.7% | legal | SEC EDGAR | MBOT 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2024-06-17 | -6.6% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-09-19 | +6.4% | legal | SEC EDGAR | MBOT 8-K: 5.02 (SEC Filing) |
| 2025-09-19 | +6.4% | news | Yahoo Finance | Microbot (MBOT) Extends 4-Day Decline on $63-Million Fundraising Program - Yahoo Finance |
| 2022-09-12 | +6.4% | analyst | TradingView | MBOT Forecast — Price Target — Prediction for 2027 - TradingView |
| 2025-01-24 | +6.4% | legal | SEC EDGAR | MBOT 8-K: 5.02 and (SEC Filing) |
| 2025-11-29 | -6.2% | news | StocksToTrade | Emory University Hospital’s Adoption Boosts Microbot Medical’s Market Presence - StocksToTrade |
| 2025-11-29 | -6.2% | news | timothysykes.com | Emory University Adopts Microbot Medical’s Liberty Robotic System - timothysykes.com |
| 2026-04-10 | -6.2% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2026-04-10 | -6.2% | news | Stock Titan | Microbot Medical (NASDAQ: MBOT) outlines $39,230,691 at-the-market stock plan - Stock Titan |
| 2026-04-10 | -6.2% | news | Stock Titan | Microbot Medical (MBOT) files ATM to raise up to $39.2M for LIBERTY® development - Stock Titan |
| 2024-01-30 | -6.1% | legal | Seeking Alpha | Microbot Medical announces settlement resolving legal matters |
| 2024-01-30 | -6.1% | legal | SEC EDGAR | MBOT 8-K: 1.01, 3.02, 7.01, 8.01 (SEC Filing) |
| 2025-08-28 | -6.1% | legal | Seeking Alpha | Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst |
| 2025-08-28 | -6.1% | legal | Seeking Alpha | Microbot Medical: LIBERTY’s Disposable Endovascular Robot Nears FDA Catalyst (NASDAQ:MBOT) - Seeking Alpha |
| 2025-06-12 | -5.7% | analyst | Yahoo Finance | Microbot Medical (MBOT) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance |
| 2025-02-12 | +5.7% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-07-09 | +5.6% | earnings | MarketBeat | Microbot Medical (MBOT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat |
| 2025-07-30 | -5.1% | legal | SEC EDGAR | MBOT 8-K: 3.02 and (SEC Filing) |
| 2024-08-01 | -4.7% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2024-02-27 | +4.7% | legal | SEC EDGAR | MBOT 8-K: 5.02 and (SEC Filing) |
| 2025-06-11 | -4.7% | legal | SEC EDGAR | MBOT 8-K: 3.03, 5.03, 5.07, 8.01 (SEC Filing) |
| 2025-09-08 | +4.7% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-09-08 | +4.7% | legal | Stock Titan | 100% Success Rate: Microbot Medical's Revolutionary LIBERTY Robot Cleared by FDA for Vascular Procedures - Stock Titan |
| 2025-09-08 | +4.7% | legal | timothysykes.com | Microbot Medical Secures Key Patent for Robotic System, Stock Rises - timothysykes.com |
| 2024-10-15 | +4.5% | news | Seeking Alpha | Microbot Medical completes human clinical trial in its ACCESS-PVI |
| 2024-10-15 | +4.5% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2024-04-15 | -4.5% | news | Seeking Alpha | Microbot Medical operations remain on track amid Middle East tensions, shares up |
| 2024-04-15 | -4.5% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2025-01-27 | -4.4% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2025-05-13 | -4.3% | news | Intellectia AI | MBOT Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI |
| 2024-01-18 | +4.2% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2022-10-11 | -4.1% | news | Seeking Alpha | Microbot Medical suspends development of its self-cleaning shunt project |
| 2025-03-25 | -4.0% | earnings | qz.com | Microbot Medical Inc. (MBOT) reports earnings - qz.com |
| 2024-07-01 | -3.8% | legal | SEC EDGAR | MBOT 8-K: 1.01 and (SEC Filing) |
| 2023-11-21 | -3.8% | legal | SEC EDGAR | MBOT 8-K: 5.02, 7.01 (SEC Filing) |
| 2023-11-14 | +3.8% | legal | SEC EDGAR | MBOT 8-K: 5.02 and (SEC Filing) |
| 2025-07-17 | -3.7% | legal | SEC EDGAR | MBOT 8-K: 3.02 and (SEC Filing) |
| 2023-10-31 | +3.6% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-09-26 | -3.6% | analyst | Yahoo Finance | All You Need to Know About Microbot Medical (MBOT) Rating Upgrade to Buy - Yahoo Finance |
| 2025-10-01 | +3.5% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-01-10 | -3.4% | legal | SEC EDGAR | MBOT 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2025-01-10 | -3.4% | legal | Stock Titan | Microbot Medical Secures $8.6M Funding to Advance LIBERTY® Robotic System Development - Stock Titan |
| 2025-01-10 | -3.4% | news | The Globe and Mail | Microbot Medical Closes $8.6 Million Registered Direct Offering - The Globe and Mail |
| 2025-10-14 | -3.3% | legal | Seeking Alpha | Microbot Medical secures US-based logistics partner to commercialize LIBERTY system |
| 2025-10-14 | -3.3% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-10-14 | -3.3% | earnings | Stock Titan | Limited Q4 2025 LIBERTY release — Microbot Medical secures U.S. logistics partner ahead of April 2026 launch - Stock Titan |
| 2023-10-24 | -3.3% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2022-09-14 | +3.2% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Microbot Medical (MBOT) - Zacks Investment Research |
| 2024-08-22 | -3.2% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2024-09-17 | -2.9% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2024-09-30 | +2.8% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2026-04-15 | -2.7% | expansion | Zacks | Microbot Medical Begins Full U.S. Launch of LIBERTY System |
| 2026-04-15 | -2.7% | expansion | TradingView | Microbot Medical Begins Full U.S. Launch of LIBERTY System - TradingView |
| 2025-09-16 | -2.7% | legal | SEC EDGAR | MBOT 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2026-01-22 | -2.5% | news | Seeking Alpha | Microbot Medical: High-Risk High-Return Stock, Still Hard To Value |
| 2026-01-22 | -2.5% | news | Seeking Alpha | Microbot Medical: High-Risk High-Return Stock, Still Hard To Value (NASDAQ:MBOT) - Seeking Alpha |
| 2025-08-27 | +2.5% | legal | SEC EDGAR | MBOT 8-K: 3.02 and (SEC Filing) |
| 2024-12-30 | +2.4% | earnings | Stock Titan | Microbot Medical Submits FDA 510(k) for Revolutionary LIBERTY Endovascular Robotic System, Eyes Q2 2025 Launch - Stock Titan |
| 2026-02-19 | -2.4% | news | Stock Titan | Single-use surgery robot aims to cut radiation in vascular care - Stock Titan |
| 2026-03-17 | -2.2% | news | GlobeNewswire | Microbot Medical® to Participate at the 38th Annual Roth Conference |
| 2026-03-17 | -2.2% | news | Stock Titan | Remote vascular surgery robot nears full market release in April - Stock Titan |
| 2026-03-17 | -2.2% | news | GlobeNewswire | Microbot Medical® to Participate at the 38th Annual Roth Conference - GlobeNewswire |
| 2026-03-17 | -2.2% | news | TipRanks | Microbot Medical Highlights LIBERTY Commercial Traction at Roth Conference - TipRanks |
| 2026-04-03 | -2.1% | news | Stock Titan | Director at Microbot Medical (NASDAQ: MBOT) awarded 10,000 stock options at $2.37 strike - Stock Titan |
| 2026-04-03 | -2.1% | news | Stock Titan | Director at Microbot Medical (NASDAQ: MBOT) granted 10,000 stock options at $2.37 - Stock Titan |
| 2026-04-03 | -2.1% | news | Stock Titan | Director at Microbot Medical (NASDAQ: MBOT) gets 10,000 options - Stock Titan |
| 2023-12-07 | +2.1% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2026-03-26 | -2.1% | news | GlobeNewswire | Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System |
| 2026-03-26 | -2.1% | news | Stock Titan | First robotic prostate embolization joins liver cancer mapping at Emory - Stock Titan |
| 2026-03-26 | -2.1% | news | Stock Titan | Emory uses Microbot Medical (NASDAQ: MBOT) LIBERTY robot for first PAE and Y-90 mapping - Stock Titan |
| 2026-03-26 | -2.1% | news | TipRanks | Microbot Medical Showcases Landmark Robotic Endovascular Procedures - TipRanks |
| 2025-09-23 | +2.1% | legal | Stock Titan | First FDA-Cleared Endovascular Robotic System: Microbot Medical's LIBERTY Set to Transform Vascular Surgery - Stock Titan |
| 2024-07-09 | -2.0% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2023-03-03 | -2.0% | earnings | TradingView | Microbot Medical Inc. Earnings and Revenue – NASDAQ:MBOT - TradingView |
| 2025-10-07 | +2.0% | legal | SEC EDGAR | MBOT 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2025-10-07 | +2.0% | news | Quiver Quantitative | Microbot Medical Inc. Completes Final Closing of Preferred Investment Options, Raising Approximately $25.2 Million - Quiver Quantitative |
| 2025-10-07 | +2.0% | news | Yahoo Finance | Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds - Yahoo Finance |
| 2024-04-24 | -1.8% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2026-03-30 | -1.7% | analyst | MSN | Microbot Medical (MBOT) price target increased by 12.50% to 7.65 - MSN |
| 2025-06-17 | +1.7% | legal | SEC EDGAR | MBOT 8-K: 3.02, 7.01, 8.01 (SEC Filing) |
| 2022-10-10 | -1.6% | news | Seeking Alpha | Microbot Medical receives patent allowance in Israel for the LIBERTY robotic system |
| 2023-12-01 | +1.5% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2021-10-23 | -1.5% | news | Benzinga | Microbot Medical Stock Short Interest Report | NASDAQ:MBOT - Benzinga |
| 2026-01-12 | +1.5% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2026-01-12 | +1.5% | news | GlobeNewswire | Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones - GlobeNewswire |
| 2026-01-12 | +1.5% | news | Stock Titan | Robot for vascular procedures cut radiation 92%, now moves toward wider use - Stock Titan |
| 2026-01-27 | -1.4% | news | simplywall.st | We're Not Very Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Rate - simplywall.st |
| 2023-08-15 | +1.4% | expansion | Seeking Alpha | Microbot Medical enters into manufacturing agreement with B.Y. Medimor |
| 2025-03-10 | +1.4% | news | Seeking Alpha | Microbot Medical files to sell 12.54M shares of common stock for holders |
| 2025-11-28 | -1.4% | analyst | Investing.com India | H.C. Wainwright reaffirms Buy rating on Microbot Medical stock at $12 - Investing.com India |
| 2026-04-23 | -1.3% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | MBOT (Microbot Medical Inc.) reports narrower Q4 2025 loss than consensus estimates, shares fall more than two percent. - High Interest Stocks - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-23 | -1.3% | earnings | Cổng thông tin điện tử Tỉnh Sơn La | MBOT (Microbot Medical Inc.) reports narrower Q4 2025 loss than consensus estimates, shares fall more than two percent. - Performance Review - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-23 | -1.3% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | Microbot Medical (MBOT) Competitive Edge | Q4 2025: Profit Exceeds Views - Market Share - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-06-05 | +1.3% | news | GuruFocus | Microbot Medical Selected for Preliminary Inclusion to Russell M - GuruFocus |
| 2025-11-05 | +1.2% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-11-05 | +1.2% | expansion | Stock Titan | Microbot Medical (NASDAQ: MBOT) starts limited release of LIBERTY; full launch April 2026 - Stock Titan |
| 2025-11-05 | +1.2% | expansion | Investing.com South Africa | Microbot Medical stock surges after commercial launch of robotic system By Investing.com - Investing.com South Africa |
| 2025-10-03 | +1.2% | legal | SEC EDGAR | MBOT 8-K: 1.01, 3.02 (SEC Filing) |
| 2025-02-25 | +1.1% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2024-05-11 | +1.1% | earnings | MarketBeat | Microbot Medical (MBOT) Stock Forecast and Price Target 2026 - MarketBeat |
| 2026-03-03 | -1.0% | news | Seeking Alpha | Microbot Medical says no impact from geopolitical events |
| 2026-03-03 | -1.0% | expansion | Stock Titan | Microbot’s LIBERTY robot heads for full US launch despite geopolitical events - Stock Titan |
| 2026-03-03 | -1.0% | news | TradingView | Microbot Medical confirms operational, commercial stability; LIBERTY limited release continues - TradingView |
| 2025-06-30 | -0.8% | news | Seeking Alpha | Microbot Medical added to the Russell Microcap Index |
| 2024-12-19 | -0.8% | legal | SEC EDGAR | MBOT 8-K: 5.02, 5.07 (SEC Filing) |
| 2025-08-25 | +0.8% | legal | SEC EDGAR | MBOT 8-K: 3.02 and (SEC Filing) |
| 2025-08-25 | +0.8% | news | Investing.com | Microbot Medical issues 3 million shares through option exercises, raises $5.9 million - Investing.com |
| 2026-04-22 | +0.8% | news | GlobeNewswire | Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY® |
| 2026-04-22 | +0.8% | news | Stock Titan | Doctors face radiation and strain risks; Microbot sees a LIBERTY opening - Stock Titan |
| 2026-04-22 | +0.8% | news | Stock Titan | Radiology safety push may aid Microbot (NASDAQ: MBOT) LIBERTY - Stock Titan |
| 2024-02-05 | -0.8% | legal | Seeking Alpha | Microbot files FDA application for clinical study of Liberty system |
| 2024-07-08 | +0.7% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2023-11-08 | +0.7% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2026-03-04 | +0.7% | news | GlobeNewswire | Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation |
| 2026-03-04 | +0.7% | news | Stock Titan | Microbot's LIBERTY robot offers less radiation, lighter gear for surgeons - Stock Titan |
| 2026-03-04 | +0.7% | news | GlobeNewswire | Microbot Medical® Aligns with Recently Adopted Policy of - GlobeNewswire |
| 2023-11-17 | +0.6% | legal | Seeking Alpha | Microbot Medical files for $75M mixed securities shelf |
| 2025-05-26 | -0.6% | news | Intellectia AI | MBOT Forecast — Price Prediction for 2026. Should I Buy MBOT? - Intellectia AI |
| 2024-12-10 | +0.5% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2026-02-05 | +0.5% | news | Stock Titan | Robot takes on cancer care: first LIBERTY system showcase to oncologists - Stock Titan |
| 2023-05-08 | -0.5% | news | Seeking Alpha | Microbot stock rises after plans of trial of LIBERTY robotic system in Brazil moves ahead |
| 2024-07-18 | -0.4% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-06-25 | +0.4% | news | Yahoo Finance | Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth - Yahoo Finance |
| 2023-11-13 | +0.4% | legal | SEC EDGAR | MBOT 8-K: 8.01 and (SEC Filing) |
| 2025-10-29 | -0.3% | news | Yahoo Finance | Down 28.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Microbot Medical (MBOT) - Yahoo Finance |
| 2026-04-14 | -0.3% | news | GlobeNewswire | Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference |
| 2026-04-14 | -0.3% | news | Stock Titan | Microbot takes its U.S.-cleared vascular robot to Needham investors - Stock Titan |
| 2026-04-14 | -0.3% | news | Stock Titan | Microbot Medical (NASDAQ: MBOT) to spotlight LIBERTY robotic system FMR - Stock Titan |
| 2024-02-20 | -0.3% | news | Seeking Alpha | Microbot Medical files to sell 1M shares of common stock for holders |
| 2026-03-24 | +0.2% | news | GlobeNewswire | Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal |
| 2026-03-24 | +0.2% | news | GlobeNewswire | Microbot Medical® Strengthens LIBERTY® Endovascular Robotic - GlobeNewswire |
| 2026-03-24 | +0.2% | expansion | Stock Titan | Peer-reviewed LIBERTY study supports Microbot Medical (NASDAQ: MBOT) launch - Stock Titan |
| 2026-03-24 | +0.2% | news | TipRanks | Microbot Medical Highlights Pivotal LIBERTY Study Publication Milestone - TipRanks |
| 2024-08-13 | +0.1% | legal | SEC EDGAR | MBOT 8-K: 7.01, 8.01 (SEC Filing) |
| 2026-04-24 | — | earnings | Zacks | Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1? |